Research Progress of Albumin-Based Composite Markers in Prognosis Evaluation of Patients with Colorectal Cancer

In recent years, the relevant components in the blood of cancer patients have been confirmed to be related to the progression of the disease, and the value of serum albumin in predicting the efficacy of colorectal cancer patients has been widely studied. In addition, with the understanding of different degrees of nutritional risk in cancer patients due to various reasons and the acceleration of disease progression, more and more studies have explored the prognostic value of nutrition-related markers in cancer patients. This article reviews the research literature on the role of albumin-related composite indicators in the prognosis of patients with colorectal cancer at home and abroad in recent years, and deeply discusses the key role of relevant composite indicators in predicting tumor prognosis and guiding clinical intervention, aiming to promote the optimization of colorectal cancer treatment programs and the improvement of patients’ prognosis.